A powerful group of conservative interest groups and activists penned a letter last week to Republican congressional leaders asking them to rein in a...
CNN admitted Wednesday policies to limit pharmaceutical TV advertising that are being considered by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr....
How Big Pharma’s web of interests groups pushes its agenda across the country
The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known...
About Eight in Ten Across Parties Say Drug Company Profits Are a Major Contributing Factor to Prescription Drug Costs
Despite seeing their general benefits to...
Ad highlights the hypocrisy of Senator Tammy Baldwin’s position on Big Pharma
FOR IMMEDIATE RELEASEOctober 25, 2024
MADISON, Wisconsin – Americans for Pharma Reform, a non-profit...
Bust Big Pharma Bus Tour
Join us as we hit the road to expose Big Pharma with Big Voices
Taking the fight right to the streets. Let your voice be heard, and let's expose the collusion between big pharma and politicians.
BOSTON, December 6, 2022 – The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription drugs in the...
If the government can’t legally constrain prescription drug prices, what can it do?
Later this year, the federal government is supposed to start a serious...
For decades, pharmaceutical companies have gamed the U.S. patent system and engaged in anticompetitive behaviors to drive up prices, making it increasingly harder for...
Overpatented, Overpriced:
This report analyzes the twelve best selling drugs in the United States and reveals that drugmakers file hundreds of patent applications – the...
As advocacy groups take a victory lap for moving lawmakers to finally allow Medicare to negotiate lower prices for 10 widely-used medicines, a new report detailed...
A group of House lawmakers has urgently called upon the Food and Drug Administration (FDA) to investigate American biopharmaceutical companies that conducted clinical trials...
Brand drug manufacturers in the United States have developed strategies to thwart generic competition and preserve monopoly profits longer than policymakers intended. In doing...
Activists argue that with large profits Big Pharma companies can afford to be more flexible around Intellectual Property, which they believe could ultimately spur...